Finance

Lists
OXOA:FRA
Oxford BioMedica plc
€5.25
+6.71%
(+0.33) 1D
Sep 7, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for OXOA...
Open
€4.78
High
€5.25
Low
€4.78
Mkt. cap
555.01M
Avg. vol.
99.00
Volume
0.00
52-wk high
€10.90
52-wk low
€4.64
No. of employees
977
Open
€4.78
High
€5.25
Low
€4.78
Mkt. cap
555.01M
Avg. vol.
99.00
Volume
0.00
52-wk high
€10.90
52-wk low
€4.64
No. of employees
977
Profile
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. Wikipedia
About Oxford BioMedica plc
CEOFrank Mathias
Employees977
Founded1995
Headquarters-
SectorBiotechnology
Websiteoxb.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
36.61M
36.61M
47.76M
47.76M
Cost of goods sold
20.78M
20.78M
30.60M
30.60M
Cost of revenue
20.78M
20.78M
30.60M
30.60M
Research and development expenses
992.00K
992.00K
1.54M
1.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.93M
26.93M
19.65M
19.65M
Operating expense
27.62M
27.62M
20.93M
20.93M
Total operating expenses
48.40M
48.40M
51.52M
51.52M
Operating income
-11.79M
-11.79M
-3.76M
-3.76M
Other non operating income
-63.50K
-63.50K
-323.00K
-323.00K
EBT including unusual items
-13.02M
-13.02M
-2.95M
-2.95M
EBT excluding unusual items
-13.02M
-13.02M
-7.26M
-7.26M
Income tax expense
423.50K
423.50K
-1.07M
-1.07M
Effective tax rate
-3.25%
-3.25%
36.20%
36.20%
Other operating expenses
-311.50K
-311.50K
-259.50K
-259.50K
Net income
-13.18M
-13.18M
-1.88M
-1.88M
Net profit margin
-36.00%
-36.00%
-3.94%
-3.94%
Earnings per share
-
-
-
-
Interest and investment income
538.00K
538.00K
649.50K
649.50K
Interest expense
-3.38M
-3.38M
-3.55M
-3.55M
Net interest expenses
-2.84M
-2.84M
-2.90M
-2.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.07M
-7.07M
-2.06M
-2.06M
Gain or loss from assets sale
-43.00K
-43.00K
53.00K
53.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps